274 related articles for article (PubMed ID: 22007736)
1. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
2. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
3. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.
Gerami P; Beilfuss B; Haghighat Z; Fang Y; Jhanwar S; Busam KJ
J Cutan Pathol; 2011 Apr; 38(4):329-34. PubMed ID: 21323721
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
Hossain D; Qian J; Adupe J; Drewnowska K; Bostwick DG
Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
[TBL] [Abstract][Full Text] [Related]
8. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
9. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
10. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
Gammon B; Gerami P
Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
[TBL] [Abstract][Full Text] [Related]
15. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
Gammon B; Beilfuss B; Guitart J; Gerami P
Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
Fang Y; Dusza S; Jhanwar S; Busam KJ
Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
Gerami P; Mafee M; Lurtsbarapa T; Guitart J; Haghighat Z; Newman M
Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
[TBL] [Abstract][Full Text] [Related]
18. FISH analysis for diagnostic evaluation of challenging melanocytic lesions.
Zimmermann AK; Hirschmann A; Pfeiffer D; Paredes BE; Diebold J
Histol Histopathol; 2010 Sep; 25(9):1139-47. PubMed ID: 20607656
[TBL] [Abstract][Full Text] [Related]
19. What's new in prognostication of melanoma in the dermatopathology laboratory?
Bangash HK; Romegialli A; Dadras SS
Clin Dermatol; 2013; 31(3):317-23. PubMed ID: 23608451
[TBL] [Abstract][Full Text] [Related]
20. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
